CIK: 1557420 - Address: C/O Windtree Therapeutics, Inc., 2600 Kelly Road, Suite 100, Warrington, PA 18976
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret117-4-7-11-29-45-59-26
S%wins1001007110010010095

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/1/14 16:01
4/30/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-9843.5533-2-1000D2535-51-23-15010-4-25-29-22-27-50
4/2/14 16:01
3/31/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-10446.2033-2-1000D23620-45-34-24-9-18-4-52-25-23-39
2/12/14 16:01
2/11/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-15167.0033-2-1000D290149-30-6-871014-2-5-23-49-54-62
1/6/14 16:02
1/2/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-16071.1133-2-1000D3391713-231413620-4-14-36-51-62
12/4/13 17:00
12/2/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-15870.4133-2-1000D327217-6-27-19-160-4-2-46-28-53-70
11/5/13 16:00
11/1/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-18783.2333-2-1000D54128294-906-7-2-9-1-16-29-58-74
10/8/13 16:58
10/7/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFraser CraigMAOP,US,IntS.d-1,86393.1633-20-1000D58352113830179-3-10-5-2-17-47-55

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact